Caring Mill Cough Drops Cherry

Description

CoughDrops-421 is a pharmaceutical formulation designed for the relief of cough symptoms. The product is presented in a lozenge dosage form, facilitating ease of administration. CoughDrops-421 is characterized by its specific active ingredients, which contribute to its therapeutic efficacy. The formulation is designed to dissolve slowly in the mouth, providing prolonged relief. The appearance of CoughDrops-421 is consistent with standard lozenge products, ensuring patient familiarity and acceptance.

Uses and Indications

This drug is indicated for the temporary relief of cough due to a cold and for the alleviation of occasional minor irritation, pain, sore mouth, and sore throat.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is recommended to consult a doctor before administration.

Contraindications

There are no contraindications listed for this product. It is important to evaluate each patient's individual circumstances and medical history before prescribing.

Warnings and Precautions

Severe sore throat symptoms warrant immediate medical attention. If a sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

Healthcare professionals should advise patients to seek medical guidance before using this product if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. Additionally, patients with a cough accompanied by excessive phlegm (mucus) should also consult a doctor prior to use.

During the use of this product, it is crucial that patients adhere strictly to the recommended dosage. Exceeding the recommended dosage may lead to adverse effects.

Patients should discontinue use and consult a healthcare provider if any of the following occur: a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious underlying condition. Furthermore, if symptoms of a sore mouth do not improve within seven days, or if irritation, pain, or redness persists or worsens, medical advice should be sought.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. A severe sore throat that persists for more than two days, especially if accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, necessitates prompt consultation with a healthcare provider.

Before using this product, patients should seek medical advice if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm (mucus).

During the use of this product, it is crucial not to exceed the recommended dosage. Patients are advised to discontinue use and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, if symptoms of a sore mouth do not improve within seven days, or if irritation, pain, or redness persists or worsens, medical advice should be sought.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been noted in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Caring Mill Cough Drops Cherry (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended administration involves dissolving the lozenge slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a physician.

It is important to note that there is a choking hazard associated with small parts for children under 4 years of age. Therefore, children should always be seated and supervised while consuming the lozenge to minimize the risk of choking.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There are no specific warnings, precautions, or dosage modifications regarding the use of Caring Mill Cough Drops in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or if there are any associated risks to the fetus. Additionally, no safety concerns related to the use of this product during pregnancy have been provided. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the benefits against any potential risks when recommending this product.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this medication.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Exceeding the recommended dosage of this product may lead to serious health consequences. Healthcare professionals are advised to monitor patients closely for any signs of overdosage and to educate patients on the importance of adhering to the prescribed dosage guidelines.

In the event of suspected overdosage, it is crucial to assess the patient for potential symptoms, which may vary depending on the specific product and individual patient factors. Common symptoms associated with overdosage may include, but are not limited to, gastrointestinal disturbances, neurological effects, and cardiovascular complications.

Management of overdosage should be initiated promptly. Healthcare providers should consider supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and, if necessary, implementing specific interventions based on the symptoms presented. In cases of severe overdosage, consultation with a poison control center or toxicology specialist is recommended to determine the most appropriate course of action.

It is imperative that healthcare professionals remain vigilant and proactive in preventing overdosage by ensuring that patients are well-informed about the risks associated with exceeding the recommended dosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children. It is important to emphasize the potential risks associated with accidental ingestion by children and to encourage patients to store medications in a secure location.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat and direct sunlight to maintain its integrity.

Healthcare professionals should also be vigilant in inspecting the primary bag seal; the product must not be used if the seal has been torn or broken, as this could compromise the safety and efficacy of the product. Proper handling and storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

For patients aged 2 years and older, the recommended administration involves dissolving the lozenge slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a clinician. For children under 2 years of age, it is advised to consult a doctor before use.

Drug Information (PDF)

This file contains official product information for Caring Mill Cough Drops Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)